|
Luminex Signs Agreement With Fisher HealthCare (SYS-CON Media)
Luminex Corporation , a leading multiplex solution developer, announces the signing of a Development and Supply Agreement with Fisher HealthCare, part of Thermo Fisher Scientific Inc. . The agreement provides Fisher HealthCare with access to Luminex xMAP(R)-based technology in the U.S. and offers Luminex a broad new customer sales channel for xMAP-based instruments and assays.
(Jan 3, 2007)
Luminex Signs Agreement With Fisher HealthCare (SYS-CON Media)
Luminex Corporation , a leading multiplex solution developer, announces the signing of a Development and Supply Agreement with Fisher HealthCare, part of Thermo Fisher Scientific Inc. . The agreement provides Fisher HealthCare with access to Luminex xMAP(R)-based technology in the U.S. and offers Luminex a broad new customer sales channel for xMAP-based instruments and assays.
(Jan 3, 2007)
Plan your move (Deccan Herald)
The new year has begun and it is time to plan the year ahead in the most important area of your life — your studies and your career.
(Jan 3, 2007)
San Antonio research institutions join on landmark brain gene study (BizJournals)
Researchers at the Southwest Foundation for Biomedical Research and the University of Texas Health Science Center at San Antonio received two cooperative grants totaling $7 million on a major study of the brain.
(Jan 3, 2007)
Flush With Cash, Southern Capitol Ventures Closes $15M Second Fund (Local Tech Wire)
Raleigh — Southern Capitol Ventures has closed on its second fund—oversubscribed at $15 million—and is actively looking for deals.
(Jan 3, 2007)
Hybrid Molecule Causes Cancer Cells to Self-destruct (Newswise)
By joining a sugar to a short-chain fatty acid compound, Johns Hopkins researchers have developed a two-pronged molecular weapon that kills cancer cells in lab tests.
(Jan 3, 2007)
Gene test predicts lung cancer relapse (New Scientist)
By analysing just five of a patient’s genes, doctors can now predict whether the cancer will recur within a few years following surgery
(Jan 3, 2007)
Medical grants attract back researchers (University of Queensland)
University of Queensland researchers have been awarded $2.89 million in the latest round of National Health and Medical Research Council grants.
(Jan 4, 2007)
Luminex Corporation to Present at JP Morgan Healthcare Conference (SYS-CON Media)
Luminex Corporation today announced that management will present at the 25th Annual JP Morgan Healthcare Conference to be held January 8-11, 2007, in San Francisco.
(Jan 4, 2007)
Impact Of Under-Reporting Calorie Intake On Dietary Patterns And Weight (Science Daily)
Assessing and meeting people's nutrition and health needs is often made more difficult when they do not accurately report what and how much they eat, according to researchers at Pennsylvania State University.
(Jan 4, 2007)
Low-Phytate Wheats: How Do They Bake? (Science Daily)
Newly developed lines of wheat with one-third less phytate than current varieties--and up to three times more phosphorus in the flour made from the wheat--are being developed by breeders. They promise to offer better nutrition, both as feed for livestock and in breads and other wheat-based foods for people.
(Jan 4, 2007)
Health care providers growing (The Arizona Republic)
In another sign of medical progress in the Northeast Valley, the Mayo Clinic plans to increase its bench research by 50 percent in the next two years, according to Mayo's head of research Dr. Laurence Miller.
(Jan 4, 2007)
Biomira starts enrolling for phase II trial of pancreatic cancer drug (PharmaBiz)
Biomira Inc has announced that the phase II clinical trial of PX-12 in patients with advanced pancreatic cancer is open for enrolment.
(Jan 4, 2007)
Gene test devised to predict lung cancer relapse risk (New Kerala)
London, Jan 4: A new gene test can predict how people with lung cancer will fare, say researchers, allowing aggressive chemotherapy to be targeted to only those who need it.
(Jan 4, 2007)
Gene test devised to predict lung cancer relapse risk (ANI via Yahoo! India News)
London, Jan 4 (ANI): A new gene test can predict how people with lung cancer will fare, say researchers, allowing aggressive chemotherapy to be targeted to only those who need it. Patients whose tests reveal a "high risk signature" of gene activity are three times as likely to experience a cancer recurrence in the five years after surgery. The test may relieve the frustration doctors ...
(Jan 4, 2007)
Livestock genetic businesses to merge (AAP via Yahoo!7 News)
Two New Zealand and Australian livestock genetic businesses are combining to form a new company, Catapult Genetics.
(Jan 4, 2007)
MBI returning to city biotech park (Worcester Telegram & Gazette)
WORCESTER - Massachusetts Biomedical Initiatives, a nonprofit group that runs business incubators for small life-science companies, will leave its leased space in a former hospital and return to the city's biotechnology park.
(Jan 4, 2007)
Epigenomics AG to Discover Biomarkers in R&D Collaboration With Centocor Inc. (RedNova)
BERLIN, Germany, Jan. 4, 2007 (PRIME NEWSWIRE) -- Epigenomics AG (Frankfurt:ECX), (Other OTC:EPGNF) has entered into an R&D collaboration with Centocor Inc., a US-based, biomedicines company, to identify and analyze potential biomarkers for use in Centocor's oncology program.
(Jan 4, 2007)
DNA Vaccine For H5N1 Avian Influenza Enters Human Trial (Science Daily)
The first human trial of a DNA vaccine designed to prevent H5N1 avian influenza infection began on December 21, 2006, when the vaccine was administered to the first volunteer at the National Institutes of Health (NIH) Clinical Center in Bethesda, MD. Scientists from the Vaccine Research Center (VRC) at the National Institute of Allergy and Infectious Diseases (NIAID), one of the NIH Institutes, ...
(Jan 4, 2007)
Hybrid Molecule Causes Cancer Cells To Self-destruct (Science Daily)
By joining a sugar to a short-chain fatty acid compound, Johns Hopkins researchers have developed a two-pronged molecular weapon that kills cancer cells in lab tests.
(Jan 4, 2007)
'Domesticated' Microbes Flex Industrial Muscle (Science Daily)
A range of tangy and tart flavor compounds in hundreds of popular food and beverage products worldwide are the result of friendly fermentative microorganisms that carry out a variety of key biosynthetic processes. Now, a consortium of public, private and academic researchers -- including three with the Agricultural Research Service (ARS) -- has decoded the DNA of nine representative strains of ...
(Jan 4, 2007)
Researchers Looking for Genes That Control the Brain (Newswise)
The largest study of its kind combines powerful resources to explain normal brain biology and shed light on the root causes of mental illness.
(Jan 4, 2007)
SeqWright to Perform FDA Standard Sequencing and Analysis for Third Wave Technologies HPV Clinical Trials (PR Newswire via Yahoo! Finance)
SeqWright, Inc., an international leader in the field of contract genomics services, announced today its selection by Third Wave Technologies, Inc. to participate in the clinical trial for two human papillomavirus screening products.
(Jan 4, 2007)
A Biomarker Strategy is a Must to Succeed in Today's Extremely Competitive Drug Development Environment Read More ... (Business Wire via Yahoo! Finance)
DUBLIN, Ireland----Research and Markets has announced the addition of Toxicity Biomarkers: Promising Tools for Accelerated Drug Development to their offering.
(Jan 4, 2007)
Ecopia Announces Agreement with Caprion to Combine their Businesses and Launch a $30 Million Private Placement (Market Wire via Yahoo! Finance)
Ecopia BioSciences Inc. and Caprion Pharmaceuticals Inc. have announced earlier today that they have entered into a combination agreement whereby they have agreed, subject to certain conditions, to combine their respective businesses through a plan of arrangement pursuant to which Ecopia and Caprion will amalgamate to form a new company with a strategic objective to create a leading oncology and ...
(Jan 4, 2007)
Ecopia Announces Agreement with Caprion to Combine their Businesses and Launch a $30 Million Private Placement (CCNMatthews via Yahoo! Finance)
MONTREAL, QUEBEC-- - Ecopia BioSciences Inc. and Caprion Pharmaceuticals Inc. have announced earlier today that they have entered into a combination agreement whereby they have agreed, subject to certain conditions, to combine their respective businesses through a plan of arrangement pursuant to which Ecopia and Caprion will amalgamate to form a new company with a strategic objective to create a ...
(Jan 4, 2007)
Growth in U.S. Corn Seed and Traits Business, Roundup Business Drive First-Quarter Sales for Monsanto Company (PR Newswire via Yahoo! Finance)
in millions)
(Jan 4, 2007)
Growth in U.S. Corn Seed and Traits Business, Roundup Business Drive First-Quarter Sales for Monsanto Company (FinanzNachrichten)
"We remain focused on delivering the next generation of innovation to the farm by offering our farmer customers meaningful seed and trait technologies. Our results in the first quarter are testament to this commitment and the value our products are providing farmers.
(Jan 4, 2007)
UPDATE: Monsanto 1Q Net Up 53% On Herbicides (Nasdaq)
Monsanto Co.'s (MON) fiscal first-quarter net income rose 53% as the seed company saw big revenue gains in its corn seed and traits as well as Roundup and other herbicides.
(Jan 4, 2007)
Lumera Showcases New Design of ProteomicProcessor(TM) at PepTalk -- Sponsors Workshop for Dr. Joshua LaBaer of Harvard ... (Business Wire via Yahoo! Finance)
BOTHELL, Wash.----Lumera Corporation , an emerging leader in the field of nanotechnology, announced today it will be showcasing the new design of its ProteomicProcessor at PepTalk, a week long conference on protein research being held in San Diego from January 8 - 12, 2007.
(Jan 4, 2007)
NIH Awards Nearly $11.5 Million to Support Science Education Programs (National Institutes of Health)
The National Center for Research Resources (NCRR), a part of the National Institutes of Health (NIH), today announced it will provide nearly $11.5 million to fund 11 Science Education Partnership Awards (SEPA) across the nation.
(Jan 4, 2007)
Corn seed and traits business, Roundup business drive first-quarter sales for Monsanto Company (SeedQuest)
“We remain focused on delivering the next generation of innovation to the farm by offering our farmer customers meaningful seed and trait technologies. Our results in the first quarter are testament to this commitment and the value our products are providing farmers.
(Jan 4, 2007)
Caprion to Merge With Ecopia Bio and Divest Its Proteomics Business (GenomeWeb News)
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription.
(Jan 4, 2007)
Media Advisory/REMINDER/Ecopia/Caprion: Notice of Conference Call (Market Wire via Yahoo! Finance)
Ecopia Biosciences and Caprion Pharmaceuticals advise of an upcoming conference call and webcast to discuss the combination of both companies and the launch of a $30 million private placement financing announced earlier this morning in a press release.
(Jan 4, 2007)
NIH awards nearly $11.5 million to support science education programs (EurekAlert!)
The National Center for Research Resources (NCRR), a part of the National Institutes of Health (NIH), today announced it will provide nearly $11.5 million to fund 11 Science Education Partnership Awards (SEPA) across the nation. The SEPA projects are designed to inform the public about health issues, foster science literacy, and encourage students to consider careers in the health sciences.
(Jan 4, 2007)
RTI hires former Quintiles exec as chief medical officer (BizJournals)
RTI International on Thursday named Claude Hughes chief medical officer and vice president of the nonprofit's genomics and molecular epidemiology program.
(Jan 4, 2007)
Former Quintiles Executive Joins RTI as Chief Medical Officer (Local Tech Wire)
RESEARCH TRIANGLE PARK, N.C. — Claude Hughes, a former executive with Quintiles Transnational, is joining RTI International as its chief medical officer.
(Jan 4, 2007)
Monsanto 1Q profit rose 53 percent (AP via Yahoo! News)
Monsanto Co. reported Thursday its fiscal first-quarter earnings surged 53 percent and the world's biggest seed company said strong early orders for next year's crop suggest it will hit the high end of its earnings guidance for the full year.
(Jan 4, 2007)
CORRECT: Monsanto reaps profits on modified corn demand (Market Watch)
SAN FRANCISCO (MarketWatch) -- Monsanto Co.'s first-quarter net income increased 53% as more farmers used its genetically modified corn seeds and Roundup weed-killer, the company reported Thursday.
(Jan 4, 2007)
CODA and Integrated Genomics Announce Collaboration to Enhance Protein Production in Pichia Yeast Expression Systems (SYS-CON Media)
CODA Genomics and Integrated Genomics (Chicago, IL) announced today a collaboration which will apply CODA's proprietary Translation Engineering(TM) protein expression technology to the Pichia yeast expression system.
(Jan 4, 2007)
Inflation-Adjusted Funding for NHGRI, DOE Genomics Program May Slide 1.5 Percent in FY’07 (GenomeWeb News)
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription.
(Jan 4, 2007)
Media Advisory/REMINDER/Ecopia/Caprion: Notice of Conference Call (SYS-CON Media)
Ecopia Biosciences (TSX: EIA) and Caprion Pharmaceuticals advise of an upcoming conference call and webcast to discuss the combination of both companies and the launch of a $30 million private placement financing announced earlier this morning in a press release. The conference call will take place today, January 04, 2007 at 3:00 p.m. eastern time.
(Jan 4, 2007)
Ecopia BioSciences and Caprion Pharmaceuticals agree to stock-swap merger (Canadian Business)
January 4, 2007 - 4:34 p.m. MONTREAL (CP) - Shares of Ecopia BioSciences Inc. (TSX:EIA) fell more than 24 per cent Thursday after the company announced a merger with Caprion Pharmaceuticals Inc. to create a new company specializing in developing treatments for cancer and infectious diseases.
(Jan 4, 2007)
Monsanto 1Q profit rose 53 percent (AP via Yahoo! News)
Monsanto Co. reported Thursday its fiscal first-quarter earnings surged 53 percent and the world's biggest seed company said strong early orders for next year's crop suggest it will hit the high end of its earnings guidance for the full year.
(Jan 4, 2007)
Avian flu chips go commercial (EETimes)
Avian flu chips validated by the U.S. Centers for Disease Control and Prevention could soon be showing up at U.S. medical clinics.
(Jan 4, 2007)
Study: Gene Tests No Use for Depression (RedNova)
Using gene-based tests designed to personalize the dose of anti-depressants has not been shown to improve patient outcomes, a new U.S. study says.
(Jan 4, 2007)
Grant to help Brown train high school science teachers (The Providence Journal)
PROVIDENCE — Brown University has received a $636,131 grant from the National Institutes of Health to train Rhode Island high school science teachers how to integrate high-level concepts and hands-on experiments into their lesson plans.
(Jan 5, 2007)
Genomic variation easier to identify with UCSD/Brown software (EurekAlert!)
PROVIDENCE, R.I. [Brown University] -- When cells reproduce, their DNA is copied – and mistakes are made. These mistakes, or mutations, range from changes in a single letter of the DNA sequence to drastic deletions, duplications or rearrangements of genetic code.
(Jan 5, 2007)
Hybrid Molecule Causes Cancer Cells To Self-destruct (Medical News Today)
By joining a sugar to a short-chain fatty acid compound, Johns Hopkins researchers have developed a two-pronged molecular weapon that kills cancer cells in lab tests. The researchers cautioned that their double-punch molecule, described in the December issue of the journal Chemistry & Biology, has not yet been tested on animals or humans. [click link for full article]
(Jan 5, 2007)
Area CEOs' pay doesn't even approach Nardelli's (The Herald-Tribune)
The business world is buzzing about some big numbers: $210 million and $64 million.
(Jan 5, 2007)
|
